Jeffrey S Glenn - Net Worth and Insider Trading
Jeffrey S Glenn Net Worth
The estimated net worth of Jeffrey S Glenn is at least $24,851 dollars as of 2024-06-09. Jeffrey S Glenn is the Director of Eiger BioPharmaceuticals Inc and owns about 11,296 shares of Eiger BioPharmaceuticals Inc (EIGRQ) stock worth over $24,851. Details can be seen in Jeffrey S Glenn's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jeffrey S Glenn has not made any transactions after 2022-12-22 and currently still holds the listed stock(s).
Transaction Summary of Jeffrey S Glenn
Jeffrey S Glenn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey S Glenn owns 1 companies in total, including Eiger BioPharmaceuticals Inc (EIGRQ) .
Click here to see the complete history of Jeffrey S Glenn’s form 4 insider trades.
Insider Ownership Summary of Jeffrey S Glenn
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EIGRQ | Eiger BioPharmaceuticals Inc | 2022-12-22 | director |
Jeffrey S Glenn Latest Holdings Summary
Jeffrey S Glenn currently owns a total of 1 stock. Jeffrey S Glenn owns 11,296 shares of Eiger BioPharmaceuticals Inc (EIGRQ) as of December 22, 2022, with a value of $24,851.
Latest Holdings of Jeffrey S Glenn
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EIGRQ | Eiger BioPharmaceuticals Inc | 2022-12-22 | 11,296 | 2.20 | 24,851 |
Holding Weightings of Jeffrey S Glenn
Jeffrey S Glenn Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey S Glenn has made a total of 3 transactions in Eiger BioPharmaceuticals Inc (EIGRQ) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Eiger BioPharmaceuticals Inc is the acquisition of 3,333 shares on December 22, 2022, which cost Jeffrey S Glenn around $128,000.
Insider Trading History of Jeffrey S Glenn
- 1
Jeffrey S Glenn Trading Performance
GuruFocus tracks the stock performance after each of Jeffrey S Glenn's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey S Glenn is 19.76%. GuruFocus also compares Jeffrey S Glenn's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey S Glenn within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeffrey S Glenn's insider trading performs compared to the benchmark.
Performance of Jeffrey S Glenn
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.9 | | | | | |
| Relative Return to S&P 500(%) | 9.83 | | | | | |
Jeffrey S Glenn Ownership Network
Jeffrey S Glenn Owned Company Details
What does Eiger BioPharmaceuticals Inc do?
Who are the key executives at Eiger BioPharmaceuticals Inc?
Jeffrey S Glenn is the director of Eiger BioPharmaceuticals Inc. Other key executives at Eiger BioPharmaceuticals Inc include 10 percent owner Richard A Kayne , 10 percent owner Leen Kawas , and Chief Business Officer Ingrid Choong .
Eiger BioPharmaceuticals Inc (EIGRQ) Insider Trades Summary
Over the past 18 months, Jeffrey S Glenn made 1 insider transaction in Eiger BioPharmaceuticals Inc (EIGRQ) with a net purchase of 100,000. Other recent insider transactions involving Eiger BioPharmaceuticals Inc (EIGRQ) include a net purchase of 27,500 shares made by Thomas John Dietz , a net purchase of 278,239 shares made by Richard A Kayne , and a net purchase of 24,332 shares made by Leen Kawas .
In summary, during the past 3 months, insiders sold 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 896 shares of Eiger BioPharmaceuticals Inc (EIGRQ) were sold and 15,086 shares were bought by its insiders, resulting in a net purchase of 14,189 shares.
Eiger BioPharmaceuticals Inc (EIGRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eiger BioPharmaceuticals Inc Insider Transactions
Jeffrey S Glenn Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey S Glenn. You might contact Jeffrey S Glenn via mailing address: 350 Cambridge Avenue, Suite 350, Palo Alto Ca 94306.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
